The glioma-associated oncogene homolog 1 (GLI1) family of zinc finger transcription factors is the nuclear mediator of the Hedgehog pathway that regulates genes essential for various stages of tumor development and progression. However, the role and mechanism by which high expression of GLI1 contributes to the invasion and metastasis of human esophageal squamous cell cancer (ESCC) has not been fully elucidated. In the present study, we demonstrated that GLI1 was over-expressed in human ESCC tissues, especially in ESCC tissues with deep invasion and lymph-node metastasis. Moreover, GLI1 was also over-expressed in ESCC cell lines and correlated with the aggressiveness of ESCC cell lines. In addition, GLI signaling pathway agonist purmorphamine could increase the invasion and metastasis ability of ESCC cells in vitro. There is increasing evidence for the contribution of epithelialmesenchymal transition (EMT) to ESCC invasion and metastasis, therefore we investigated GLI1's role in EMT. Our results showed that high expression of GLI1 dampened expression of E-cadherin and enhanced the expression of Vimentin, and it also improved the expression of Snail, indicative of its role in EMT occurrence. Mechanistic studies showed that down-expression of Snail reversed GLI1 activation-regulated expression of EMT markers, suggesting the role of Snail in GLI1-mediated EMT. Taken together, our results had revealed that GLI1 could participate in the invasion and metastasis of ESCC through EMT. These studies indicated that in ESCC, GLI1 could be a useful target for cancer prevention and therapy.
INTRODUCTION
Esophageal cancer (EC) is one of the most common primary gastrointestinal cancers in the world and China is one of the countries with the highest incidence of ESCC worldwide, and esophageal squamous cell carcinoma (ESCC) accounts for 90% of ECs in China. 1 Despite improvements in surgical technique, enhanced imaging, and new chemotherapeutic agents, outcomes for patients remain extremely poor because of the early invasion and metastasis of EC cells. 2 Therefore, it is essential to have a discussion about the mechanism of invasion and metastasis of ESCC.
The process of invasion and metastasis of cancers has many major steps, while the first step is that the metastatic tumor cells must acquire the ability to emigrate from the primary tumor. 3 Until now the most comprehensive theory describing how initially quiescent tumor cells acquire metastatic capability is the epithelial-mesenchymal transition (EMT). 4 EMT is a developmental process that allows cells that are a part of a rigid architecture to escape and spread to distant sites. When cells undergo EMT, they lose their epithelial features including their sheet-like architecture and polarity, undergo downregulation of its molecular hallmark E-cadherin. 5 The cells also develop a mesenchymal phenotype, taking on a spindle-like, fusiform morphology, become motile, and start expressing mesenchymal markers, for example, N-cadherin, fibronectin and Vimentin. 3 A primary group of transcription factors appear to affect many of the changes seen in EMT. These include Snail, Slug, Twist, ZEB1 and -2, the Smad proteins and microRNAs among others, [6] [7] [8] while Snail is the first discovered and most important transcriptional repressor of E-cadherin. These transcription factors all directly or indirectly affect E-cadherin transcription. The signaling regulation of EMT is wide and incredibly complex, involving activation of a number of different pathways, for example, TGF-b, Wnt, Notch, Hedgehog and so on. 9 The Hedgehog signaling pathway (Hh pathway) regulates normal cell growth and differentiation. 10 When deregulated, the Hh pathway leads to tumorigenesis and supports more aggressive phenotypes of human cancers, such as progression, metastasis and therapeutic resistance. 11 The Hh pathway is initiated by Sonic hedgehog (Shh), Indian hedgehog (Ihh) and Desert hedgehog (Dhh), with Shh being the most potent of the three. The main effectors of Shh signaling are the GLI transcription factors GLI1, GLI2 and GLI3, while Shh addition to cells induces GLI protein translocation to the nucleus to affect gene transcription. 12 A number of studies have identified downstream targets of GLI proteins that may be relevant to tumor formation and metastasis; these include MMP-9, MMP-2, E-cadherin, S100a4, Bcl-2, members of the Wnt/b-catenin family as well as a number of growth factors and cell cycle proteins. 13, 14 GLI1 has been reported to be overexpressed in several cancer tissues including glioblastoma, breast cancer, and pancreatic adenocarcinoma among several others.
proliferation of cells. Inhibition of Shh-GLI1 signaling by cyclopamine or siRNA targeting of GLI1 reduces cell proliferation and tumor size. 15 GLI1 expression is positively correlated with tumor grade and lymph-node status, indicating a role for GLI1 in metastasis. Thus, these GLI1 forms may have a role in cancer development and progression.
However, it is still unclear whether GLI transcription factors (such as GLI1) take part in the invasion and metastasis of ESCC and whether the mechanism by which the GLI1 promotes tumor invasion and metastasis is associated with the regulation of EMT in ESCC. Thus, to further explore the role and possible mechanism of GLI1 in the invasion and metastasis of ESCC, we used esophageal squamous cancer cell lines: EC-1, EC-9706 and TE-1. We demonstrated the presence of GLI1 in ESCC tissues and cells and that GLI1 activation takes part in the invasion and metastasis of ESCC cells by participating in EMT via Snail.
MATERIALS AND METHODS

Reagents and antibodies
Shh-GLI1 signaling pathway agonist purmorphamine was from TESTMART (Shanghai, China). Snail siRNA and nonsense siRNA were from Shanghai GenePharma (Shanghai, China). Boyden Chamber for metastasis and invasion assay was obtained from Chinagenecell (Zhengzhou, China). Antibodies against GLI1, E-cadherin, Vimentin were from Sigma (St Louis, MO, USA). Antibodies against Snail were from BD (New York, NY, USA). Trizol and Lipofectamine reagents were from Invitrogen (Carlsbad, CA, USA). TransScript First-strand cDNA Synthesis SuperMix kit and STBR Premix Ex Taq kit were from TaKaRa Bio (Shiga, Japan). 
Tissue specimens
Immunohistochemistry assay
Immunohistochemistry was performed as described below. The slides were incubated with the following primary antibody: anti-GLI1, 1:100 dilution; anti-rabbit peroxidase-conjugated secondary antibodies were applied. The sections were visualized by diaminobenzidin and counterstained with hematoxylin. The sections were observed under a microscope after being mounted. The application of primary antibodies to tissue sections was omitted in negative controls. At least five thin sections of tumor tissue were used for quantitative immunohistochemistry. For negative controls, the anti-Gli1 antibody was replaced with PBS. We assessed immunohistochemical staining only in normal epithelial and tumor cells. Intensity and scoring of the immunohistochemical staining were determined by an experienced pathologist (S Min) following instructions of the scoring system suggested by Remmele et al. 16 The percentage of positive cells was rated as follows: 1, 1-10% positive cells; 2, 11-50%; 3, 51-80% and 4, 480% positive cells. Staining intensity was scored as 1, weak; 2, moderate and 3, intensive. Scores for percentage of positive cells and scores for expression intensities were multiplied to calculate an immunoreactive score; 0-2 ¼ no staining; X2 ¼ staining.
Tumor cell preparation and cell culture
The following human ESCC cell lines were used: EC-1, EC-9706 and TE-1. All three ESCC cell lines were cultured in RPMI 1640 medium with 10% fetal bovine serum. The cells were cultured at 37 1C in a humidified atmosphere containing 5% CO 2 .
Transfection TE-1 cells were transfected with 100 nM specific Snail siRNA and nonsense siRNA, using Lipofectamine reagent in serum-free 1640 medium according to the manufacturer's instruction. Untreated TE-1 cells were used as negative controls. Efficacy of transfection was tested in TE-1 cells by quantitative real-time RT-PCR or western blot. All studies were done in triplicates.
Quantitative real-time RT-PCR Total RNA was extracted by Trizol reagent, according to the manufacturer's instructions, from EC-1 and EC-9706, TE-1 and TE-1 cells from different groups. Total RNA was reverse transcribed and amplified by using transScript First-strand cDNA Synthesis SuperMix kit. To confirm the expression of GLI1, in EC-1, EC-9706 and TE-1, and expression of GLI1, Snail, E-cadherin and Vimentin in TE-1 cells from different groups, the real-time PCR was performed by using STBR Premix Ex Taq kit. Determination of GLI1. Snail, E-cadherin and Vimentin was performed over 40 cycles with 15 s at 95 1C, annealing at 60 1C for GLI1 and Snail, 55 1C for E-cadherin and Vimentin for 20 s, extension at 72 1C for 30 s and data acquisition at 78 1C.
Primer sequences are shown in Table 1 .
Western blot assay EC-1, EC-9706, TE-1 and TE-1 cells from different groups were harvested and lysed in modified radioimmune precipitation assay lysis buffer with 150 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 0.5% deoxycholic acid, 2 mg ml À 1 aprotinin, 1 mM phenylmethylsulfonyl fluoride, 5 mM benzamidine, 1 mM sodium orthovanadate and 10 mg ml À 1 soybean trypsin inhibitor in 50 mM Tris buffer, pH 7.4. The proteins separated by SDS-PAGE gel electrophoresis were then transferred onto a nitrocellulose membrane. After blocking with 0.1% Tween 20 and 5% nonfat dry milk in Tris-buffered saline at room temperature for 1 h, the membrane was incubated with primary antibody (GLI1: 1:400, Snail: 1:400, E-cadherin: 1:500 and Vimentin: 1:500) at 4 1C overnight and horseradish peroxidase-conjugated secondary antibody (1:2000) for 1 h. The levels of GLI1, Snail, E-cadherin, Vimentin and b-actin were quantitated by densitometric scanning of the X-ray films with UVP's (LLC, Upland, CA, USA) gel documentation system GDS8000 and one-dimensional gel analysis software. Experiments were performed three times for each experimental condition.
Boyden chamber invasion assay
Boyden chamber invasion assay, as previously described, was used to measure the invasiveness of the TE-1 cells from different experimental groups. Analysis of cell migration was performed using Boyden chambers according to the manufacturer's protocol. For cell invasion study, the inserts of the chamber were prepared by coating the upper surfaces with TE-1 cells BD Matrigel (Franklin Lakes, NJ, USA) (3 Â 10 3 ) treated with 1640 medium without fetal bovine serum were plated to the upper chamber. 1640 medium with 20% fetal bovine serum as chemoattractants were plated in the lower chamber of the 24-well plates. After 24-h incubation, non-invading cells were removed mechanically from the upper chamber using a cotton swab. Cells that migrated or invaded to the lower surface of the transwell membrane were fixed in methanol for 30 min at 37 1C and stained with 0.05% crystal violet for 1 h. Cells were quantified Immunofluorescence assay Cells were prepared on 0.1% gelatin-coated glass cover-slips and adherent cells were fixed in 4% paraformaldehyde for 15 min, blocked with 10% goat serum containing 0.5% Triton X-100 in PBS for 30 min, and then incubated with mouse monoclonal anti-GLI1 antibody (1:100) overnight at 4 1C. After three rinses with PBS, the samples were incubated with Cy3-conjugated goat anti-mouse secondary antibody (1:100) for 1 h at room temperature in the dark. The slides were then washed in PBS and stained with 300 nM diamidinophenylindole for 10 min followed by three rinses with PBS. After mounting with fluorescent mounting media, the slides were observed under a fluorescence microscope.
Wound-healing assay TE-1 cells were seeded into a six-well plate and allowed to grow to 70% confluency in 1640 medium. Cell monolayers were wounded by a plastic tip (1 mm) that touched the plate. Wounded monolayers were then washed for several times with PBS to remove cell debris. Cells migrated into wound surface and the average distance of migrating cells was determined under an inverted microscope after 24 h.
Statistical analysis
The database was set up with the SPSS 11.0 software (Sellers, Zhengzhou, China) package for analysis. Data were presented as mean ± s.d. The means of multiple groups were compared with one-way analysis of variance, after the equal check of variance, and the two-two comparisons among the means were performed using the least-significant difference method. Statistical comparison was also performed with two-tailed t-test when appropriate. Po0.05 was considered statistically significant.
RESULTS
Expression of GLI1 in ESCC tissues and its clinicopathological significance Expression of GLI1 was examined by immunohistochemical analysis of primary malignant tumors and adjacent benign esophageal tissues from 64 patients with esophageal carcinoma of various stages. GLI1 protein was expressed mainly in the cytoplasm and nucleolus. The positive expression of GLI1 protein in the tissues of ESCC was 68.8%, which was significantly different from those in normal mucosa (20.3%) ( Figure 1 , Table 2 ). The ESCC specimens had statistically significantly higher levels of positive expression of GLI1 than normal mucosa (Po0.01). More importantly, the expression levels of GLI1 proteins in ESCC were positively correlated with invasion depth and lymph-node metastasis ( Table 3) .
Expression of GLI1 in three ESCC cell lines
The expression pattern of GLI1 in the cultured human ESCC cell lines was investigated by immunofluorescence assay, quantitative realtime RT-PCR and western blotting. GLI1 protein expression was detectable in all cell lines by immunofluorescence assay (Figure 2a) . It can also be seen that both mRNA and protein expression of GLI1
were detected in all the three ESCC cell lines (Figure 2b and c) . More importantly, a correlation was found to exist between aggressiveness of the cell line and expression of GLI1 in all the three ESCC cell lines; the EC-1 with high metastatic ability revealed the highest GLI1 protein expression, whereas the poorly metastatic ESCC cell line, TE-1, had the lowest GLI1 protein expression.
Effect of GLI 1 over-expression on migration and invasion As in the three ESCC cell lines, TE-1 cells showed the lowest expression of GLI1, and in order to promote the expression of GLI1 in TE-1 cells, we decided to use purmorphamine (0.5, 1 and 2 mmol l À 1 ), a purine derivative specifically activating Hh-GLI1 signaling through direct Smo binding. Purmorphamine has been shown to be specific to Hh-GLI1 signaling using high-density microarray, and this drug is not toxic or mitogenic for TE-1 cells. TE-1 cells were treated with 1640 medium, in the presence (0.5, 1 and 2 mmol l À 1 ) or absence of purmorphamine (as blank control) for 48 h. TE-1 showed a significant increase in GLI1 mRNA expression compared with that in the control group; moreover, GLI1 protein expression was also increased greatly compared with that in control group (Figure 3a and b) . Furthermore, it is dosedependent. These data indicate that GLI1 expression could be effectively increased in TE-1 cells treated with purmorphamine for 48 h, especially 2 mmol l À 1 purmorphamine for 48 h. As previously mentioned, metastasis is an important characteristic of malignant cancer cells. To further assess the influence of GLI1 on ESCC cell invasion, the effect of GLI1 over-expression on cell invasion and metastasis ability was examined in TE-1. Boyden chamber invasion assay showed that over-expression of GLI1 significantly increased the invasiveness of TE-1 cells and it is also dose-dependent. The average cell counts of TE-1 cells in the presence of different concentration of purmorphamine invading through the membrane was much more than those TE-1 cultured in the absence purmorphamine. These data indicated that GLI1 might be a key factor stimulating invasion and metastasis in ESCC cells (Figure 3c and d) .
Effect of GLI1 over-expression on Snail, E-cadherin and Vimentin A series of mechanisms are involved in the metastasis of ESCC, and EMT has a particularly critical role. EMT denotes a process in which cells change their phenotype between epithelial and To address this issue, we focused on Snail, which is considered as the master regulator of EMT and is an example of a direct suppressor of E-cadherin. As shown in Figure 4 , real-time quantitative PCR analysis demonstrated that GLI1 over-expression in TE-1 cells significantly increased Snail and Vimentin mRNA expression compared with that in blank control group, while the mRNA expression of E-cadherin decreased significantly compared with that in blank control group. Similar results were observed by western blot analysis as well.
Depletion of Snail rescued GLI1 over-expression-mediated suppression of EMT In order to further investigate the role of Snail in GLI1-elicited EMT, a Snail siRNA was transfected into TE-1 cells for 48 h. Over-expression of GLI1 enhanced Snail expression, while downregulation of Snail reversed the strengthening effects. Furthermore, low expression of Snail reversed expression of E-cadherin and Vimentin in the TE-1 cells treated with GLI1 agonist (Figure 5a and b). Consequently, low expression of Snail also rescued the increased migration and invasion ability induced by GLI1 agonist. Thus, our results suggest that Snail has an important role in GLI1-regulated EMT of ESCC (Figure 5c and d) .
DISCUSSION
The Hh signaling pathway regulates normal cell growth and differentiation. When deregulated, the Hh pathway leads to tumorigenesis and supports more aggressive phenotypes of human cancers, such as progression, metastasis and therapeutic resistance. 10, 11 The glioma-associated oncogene homolog 1 (GLI1) family of zinc finger transcription factors is the nuclear mediator of the Hh pathway that regulates genes essential for various stages of tumor development and progression. 17, 18 GLI1 expression is positively correlated with tumor grade and lymph-node status, indicating a role for GLI1 in metastasis. 19 However, little is known about its expression pattern and biological significance in ESCC. In the current study, immunohistochemical analysis confirmed that tumor tissues exhibited abundant GLI1 expression, in contrast to adjacent non-tumor tissues that displayed absent or lower GLI1 expression. To investigate whether GLI1 expression might be associated with the progression and metastasis of ESCC, the GLI1 expression levels and the clinic pathologic characteristics of patients with ESCC were compared by immunohistochemistry. We found that high GLI1 expression is significantly correlated with histological grade and lymph-node metastasis. We also showed that GLI1 expression determined by real-time quantitative PCR and western blot was significantly higher in ESCC cell lines than that in normal immortalized esophageal epithelial cell line. More importantly, the expression of GLI1 in all the three ESCC cell lines was found to be positively correlated with the aggressiveness of the cell line: the EC-1 with high metastatic ability revealed the highest GLI1 protein expression, whereas the poorly metastatic ESCC cell line: TE-1 with the lowest GLI1 protein expression. These findings are in agreement with studies in other human cancers over-expressing GLI1.
To further confirm the role of GLI1 in the invasion and metastasis of ESCC, we picked up TE-1 with relatively lower GLI1 expression levels for further study. We employed GLI1 agonist purmorphamine to enhance the expression of GLI1 in TE-1 cells. Our study suggested that TE-1 cells treated with purmorphamine for 48 h, had a significant increase in the number of cells that traversed the membrane compared with that in blank control groups. We found that upregulation of GLI1 could promote cell migration and invasion ability.
It has been clearly shown in a variety of model systems that cancer cells use EMT to downregulate their cell-cell contacts and to become motile and invasive. 20, 21 Many authors regard EMT as a major mechanism enabling metastasis and initiating the transition between benign and malignant disease. A hallmark of EMT is the loss of E-cadherin expression, an important caretaker of the epithelial phenotype. 22 Several transcription factors have been implicated in the transcriptional repression of E-cadherin, for example, Snail/Slug family, Twist, Zeb and so on, and the first discovered and most important of these repressors is Snail. Some studies indicated that Snail was implicated in the initial migratory phenotype of primary tumors and considered as an early marker of EMT. [23] [24] [25] Our study had indicated a critical role of GLI1 in EMT and revealed its molecular mechanism. Here, we showed that upregulation of GLI1 by purmorphamine led to increased expression of Snail and Vimentin and reduced expression of E-cadherin. These results suggest that the enhancement of GLI1 expression has the potential to lead to the occurrence of EMT. Then, we hypothesized that a relationship exists between GLI1 and Snail and we tried to examine whether inhibiting the activity of Snail could rescue epithelial characteristics and deplete mesenchymal features of ESCC cells, which were modulated by GLI1 agonist. In the present study, Snail-low-expression treatment increased the expression of E-cadherin and reduced the expression of Vimentin. Also, the low expression of Snail inhibited the migratory ability of ESCC cells. These data suggested GLI1 could induce EMT through activation of Snail in ESCC cells.
In summary, the present study showed that GLI1 expression was upregulated in the majority of ESCC tissues and the expression of GLI1 was correlated with the aggressiveness of ESCC cells. We also presented experimental evidence that downregulation of GLI1 in ESCC cells inhibited cell invasion and metastasis ability. Furthermore, we had identified GLI1 as one of the key regulator of EMT and it exerts its function by specifically influencing the expression of Snail in ESCC. Owing to its major role in tumor invasion and metastasis, GLI1 may serve as an effective target for cancer diagnosis and therapy.
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